William Gentry
Reproductive Endocrinology · Indianapolis, INNPI 1215948427
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $154,650 of the $162,638 with a category attached, or 95.1%. AbbVie accounts for 99.1% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $95,370 and has fallen 99.8% since, to $146 in 2025. Among reproductive endocrinology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 313 payments — averaging $519.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$161K
- Myovant Sciences Inc.$283
- Ferring Pharmaceuticals Inc.$219
- Gynesonics, Inc.$136
- Hologic Sales And Service, LLC$132
- Sumitomo Pharma America, Inc.$126
- plus $549 from 9 others
What the payments were for
- Speaking & faculty fees$154,65095%
- Travel & lodging$3,3412%
- Food & beverage$4,6463%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 250 | $161,193 |
| Myovant Sciences Inc. | 16 | $283 |
| Ferring Pharmaceuticals Inc. | 11 | $219 |
| Gynesonics, Inc. | 1 | $136 |
| Hologic Sales And Service, LLC | 2 | $132 |
| Sumitomo Pharma America, Inc. | 6 | $126 |
| Organon | 3 | $94 |
| Vertical Pharmaceuticals, LLC | 5 | $86 |
| Pfizer | 4 | $76 |
| Galen US Inc | 3 | $72 |
| Astellas Pharma US Inc | 4 | $70 |
| EMD Serono, Inc. | 4 | $65 |
| Coopersurgical, Inc. | 2 | $48 |
| Merck | 1 | $19 |
| Virtus Pharmaceuticals LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$162,638 in reported general payments places this provider in the 95th percentile of 20 reproductive endocrinology providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $70 |
| Diazepam | 13 | $40 |
Paid to pharmacies, not to this prescriber.
Other reproductive endocrinology in Indianapolis
- Marguerite ShepardIndianapolis$25K
- Meredith ProvostIndianapolis$1K
- James DonahueIndianapolis$586
- David CarnovaleIndianapolis$364
- Daniel GriffinNewburgh$30K
- Kenneth MoghadamCarmel$8K
- Kathleen O'LearyCarmel$6K
- Rebecca ChilversNewburgh$2K
- Bradford BoppCarmel$2K
- David McLaughlinNoblesville$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.